🇺🇸 FDA
Patent

US 9840483

Radiomitigating pharmaceutical formulations

granted A61PA61P29/00A61P35/00

Quick answer

US patent 9840483 (Radiomitigating pharmaceutical formulations) held by The Regents of the University of California expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P29/00, A61P35/00, A61P39/06